Arnuity Ellipta vs Flovent: Key Differences That Matter

TL;DR

• Arnuity Ellipta is once-daily; Flovent requires twice-daily dosing same clinical effectiveness, different convenience level
• Flovent has a generic available for under $50; Arnuity Ellipta has no generic and costs significantly more without insurance
• Flovent is approved from age 4; Arnuity Ellipta starts at age 5 both are maintenance inhalers and neither treats acute attacks

If your doctor or pharmacist mentioned both Arnuity Ellipta and Flovent as options for your asthma maintenance treatment and you are trying to figure out which one makes more sense for your life, the comparison is worth understanding carefully. They look similar on the surface both are inhaled corticosteroids, both contain a form of fluticasone, and both do essentially the same job of keeping airway inflammation under control. But the differences between them are real and practical, and they matter for things like how you take them, what they cost, and who they are best suited for.

What Are These Medications and How Do They Work?

Both Arnuity Ellipta and Flovent belong to a class of medications called inhaled corticosteroids, or ICS. These are the backbone of long-term asthma control for the majority of people with persistent asthma. They work by reducing inflammation in the airways calming the chronic irritation that makes airways narrower, more reactive, and prone to asthma episodes.

Neither medication provides immediate relief. They are not rescue inhalers and should never be used during an acute asthma attack. Their job is prevention used consistently every day, they lower the frequency and severity of flare-ups over time. Most people notice meaningful improvement in breathing and reduced rescue inhaler use within one to two weeks of starting them, with the full effect building over several weeks of regular use.

The Active Ingredient Difference Does It Matter?

Both medications contain a form of fluticasone, but they are not the same molecule. Flovent contains fluticasone propionate. Arnuity Ellipta contains fluticasone furoate. These are structurally distinct compounds with different pharmacokinetic properties meaning they behave differently in the body even though they both end up doing the same job.

Fluticasone furoate has a longer half-life in lung tissue, which is what makes once-daily dosing effective. It binds more strongly to glucocorticoid receptors in the airway and stays active for a full 24-hour period. Fluticasone propionate has a shorter duration, which is why Flovent requires twice-daily dosing to maintain consistent anti-inflammatory coverage.

A meta-analysis published through NIH directly compared the two molecules at clinically relevant doses fluticasone furoate 100 mcg once daily versus fluticasone propionate 250 mcg twice daily and found no statistically significant difference in lung function improvement between the two. The researchers concluded that fluticasone furoate was non-inferior to fluticasone propionate for controlling persistent asthma. The full meta-analysis comparing fluticasone furoate and fluticasone propionate is available through NIH

In plain terms: the molecules are different, but the clinical outcome for most patients is equivalent.

Dosing Frequency The Most Practical Difference

This is where most people's day-to-day experience diverges between the two inhalers.

Flovent requires two inhalations, twice daily morning and evening. That is four actuations per day, taken on a consistent schedule. Missing doses, particularly in the evening, is one of the most common reasons maintenance inhalers underperform for patients in real-world use.

Arnuity Ellipta requires one inhalation, once daily. The Ellipta device is designed around this it advances one dose automatically each time you open the cap and provides a dose counter so you always know how many are remaining. For many people, the simplicity of one daily dose at the same time each morning is meaningfully easier to maintain consistently.

Research on inhaled corticosteroid adherence consistently shows that once-daily regimens outperform twice-daily regimens in real-world compliance not because patients are forgetful, but because the structure of a single daily habit is genuinely easier to embed in a routine.

Inhaler Type and Device Differences

Flovent comes in two device formats: Flovent HFA and Flovent Diskus. The HFA is a traditional pressurized metered-dose inhaler you press the canister and inhale simultaneously. It requires coordination between pressing and breathing and works well with a spacer device if coordination is an issue. The Diskus is a dry powder inhaler that delivers a pre-measured powder dose without propellant. Flovent HFA is lactose-free, which matters for people with severe milk protein allergies since the Diskus formulation contains lactose as a carrier.

Arnuity Ellipta comes only as a dry powder inhaler in the Ellipta device format. It does not use a propellant, is not compatible with a spacer, and requires a firm inhalation to deliver the powder effectively. People who have difficulty generating a strong enough inhalation particularly some older adults or those with severely compromised lung function may find the pressurized HFA format of Flovent more accessible.

Age Approvals and Pediatric Use

For families managing childhood asthma, the age approval difference is worth noting. Flovent HFA is FDA-approved from age 4 and older. Flovent Diskus is approved from age 4 as well. Arnuity Ellipta is approved from age 5 and older.

For a 4-year-old who needs an inhaled corticosteroid, Flovent is the available option. From age 5 onward, both can be considered. In practice, the choice for younger children often also depends on which device they can use correctly, and the pressurized MDI with a spacer tends to be more practical for children under 6 or 7 than a dry powder inhaler.

Cost and Insurance Coverage

This is where the practical difference between the two options is most stark for many patients.

Flovent had its original branded versions discontinued in early 2023, but authorized generic versions fluticasone propionate HFA and fluticasone propionate Diskus are now available and are considered therapeutically equivalent. These generics are significantly more affordable, with prices in the range of $50 to $80 per inhaler using discount programs. Insurance formularies typically cover them well.

Arnuity Ellipta has no generic version and no authorized generic. The brand-name cost runs approximately $250 to $350 per month without insurance. GSK announced a $35 per month out-of-pocket cap for eligible insured patients across their inhaler portfolio in 2024, which helps significantly. But for uninsured patients, Arnuity Ellipta remains substantially more expensive than the generic Flovent options.

If cost is a primary consideration particularly if you have high-deductible insurance or are paying out of pocket the generic fluticasone propionate options represent the same clinical effectiveness at a fraction of the price.

For a fuller understanding of how asthma management works and what role inhaled corticosteroids play alongside rescue inhalers and other treatments, this overview of asthma and wheezing symptoms covers the full management picture clearly.

Side Effects Are They Any Different?

The side effect profiles of the two inhalers are very similar, because both are inhaled corticosteroids delivered locally to the airways with minimal systemic absorption at recommended doses.

The most common side effects for both include oral thrush a fungal infection in the mouth and throat caused by steroid residue. Rinsing your mouth with water and spitting thoroughly after every use is the most effective prevention, regardless of which inhaler you use. Hoarseness or voice changes are also common and are caused by the steroid depositing on the vocal cords. Upper respiratory infections, headache, and sinusitis are reported with similar frequency for both medications.

At higher doses used long-term, both fluticasone propionate and fluticasone furoate can cause systemic effects including potential effects on bone density and adrenal function. These are dose-dependent and far more relevant at maximum doses than at the standard low-to-medium doses most patients use. Your provider will consider this in the overall risk-benefit calculation when selecting a dose.

One minor practical difference: Flovent HFA contains no lactose and may be preferable for the rare patient with a severe milk protein allergy. The Ellipta dry powder device uses lactose as a carrier, which is relevant in that specific situation.

Which One Is Right for You?

The right choice depends on a few factors that are specific to your situation.

Arnuity Ellipta makes the most sense if you want once-daily simplicity, are 5 years or older, prefer a dry powder inhaler, and have insurance coverage that brings the cost to a manageable level. The convenience advantage of once-daily dosing is real and supported by adherence data.

Flovent specifically the generic fluticasone propionate options makes the most sense if cost is a significant concern, if you need the MDI format for younger children or spacer compatibility, if you have a severe milk protein allergy, or if you are already well-controlled on it and see no reason to switch.

Neither is measurably more effective than the other at comparable doses. The decision comes down to convenience, cost, and your specific circumstances. For an overview of what ongoing respiratory symptom patterns and medical history look like in the context of choosing an asthma treatment, this guide to respiratory concerns and medical history is helpful context.

Conclusion

Arnuity Ellipta and Flovent are both effective inhaled corticosteroids for maintaining asthma control, and clinical research confirms they perform equivalently when used at appropriate doses. The real differences are about practicality: once-daily versus twice-daily dosing, a dry powder inhaler versus an MDI option, and a significant cost gap that favors the generic Flovent options for price-sensitive patients.

For most adults who can use a dry powder inhaler correctly and have insurance coverage, Arnuity Ellipta's once-daily convenience is a genuine benefit worth considering. For families managing childhood asthma from age 4, patients with milk allergies, or anyone without strong insurance coverage, generic fluticasone propionate inhalers deliver the same clinical result at a much more accessible cost. Your provider and pharmacist can help you weigh these factors for your specific situation.